Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

doi:10.1183/09031936.00011015

. 2015 Sep;46(3):871-4.

doi: 10.1183/09031936.00011015. Epub 2015 Mar 18.

Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

Mehdi Mirsaeidi¹, Maham Farshidpour², Deborah Banks-Tripp³, Sarah Hashmi³, Carrie Kujoth³, Dean Schraufnagel⁴

Affiliations

¹ DuPage County Health Department, Wheaton, IL, USA University of Illinois at Chicago, Chicago, IL, USA mmirsae@uic.edu.
² University of Illinois at Chicago, Chicago, IL, USA.
³ DuPage County Health Department, Wheaton, IL, USA.
⁴ DuPage County Health Department, Wheaton, IL, USA University of Illinois at Chicago, Chicago, IL, USA.

PMID: 25792632
PMCID: PMC4558232
DOI: 10.1183/09031936.00011015

Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

Mehdi Mirsaeidi et al. Eur Respir J. 2015 Sep.

. 2015 Sep;46(3):871-4.

doi: 10.1183/09031936.00011015. Epub 2015 Mar 18.

Authors

Mehdi Mirsaeidi¹, Maham Farshidpour², Deborah Banks-Tripp³, Sarah Hashmi³, Carrie Kujoth³, Dean Schraufnagel⁴

Affiliations

¹ DuPage County Health Department, Wheaton, IL, USA University of Illinois at Chicago, Chicago, IL, USA mmirsae@uic.edu.
² University of Illinois at Chicago, Chicago, IL, USA.
³ DuPage County Health Department, Wheaton, IL, USA.
⁴ DuPage County Health Department, Wheaton, IL, USA University of Illinois at Chicago, Chicago, IL, USA.

PMID: 25792632
PMCID: PMC4558232
DOI: 10.1183/09031936.00011015

No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Disclosures can be found alongside the online version of this article at erj.ersjournals.com.

Figures

**Figure 1**
a) video directly observed therapy (V-DOT) process and b) results of the survey on the patients using it DOT: directly observed therapy.

See this image and copyright information in PMC

Cited by

Use of Smartphone-Based Video Directly Observed Therapy to Increase Tuberculosis Medication Adherence: An Interventional Study.
M Al Daajani M, J Alsahafi A, M Algarni A, L Moawwad A, A Osman A, Y A Algaali K, Abdalaziz M, A Halwani M, M Aldajani S, M H Mohammed N, S Alshamrani H, N Alshahrani M, M Albostani G, G Alshammari N, S Alzahrani R, O Alsomali S, Assiri I. M Al Daajani M, et al. Galen Med J. 2023 Jul 3;12:1-8. doi: 10.31661/gmj.v12i.3067. eCollection 2023. Galen Med J. 2023. PMID: 39464537 Free PMC article.
Effectiveness of Video-Observed Therapy in Tuberculosis Management: A Systematic Review.
Sundaram KK, Ahmad Zaki R, Shankar D, Hoe V, Ahmad NAR, Kuan WC, Anhar ABN. Sundaram KK, et al. Cureus. 2024 Oct 16;16(10):e71610. doi: 10.7759/cureus.71610. eCollection 2024 Oct. Cureus. 2024. PMID: 39417069 Free PMC article. Review.
Video-observed therapy (VOT) vs directly observed therapy (DOT) for tuberculosis treatment: A systematic review on adherence, cost of treatment observation, time spent observing treatment and patient satisfaction.
Areas Lisboa Netto T, Diniz BD, Odutola P, Dantas CR, de Freitas MCFLC, Hefford PM, Bes TM. Areas Lisboa Netto T, et al. PLoS Negl Trop Dis. 2024 Oct 15;18(10):e0012565. doi: 10.1371/journal.pntd.0012565. eCollection 2024 Oct. PLoS Negl Trop Dis. 2024. PMID: 39405342 Free PMC article.
Investigating the efficacy of integrating video-directly observed therapy (VDOT) in the treatment of tuberculosis (TB): A statewide analysis from Florida.
Raj A, Khakoo NS, Ashkin AA, Green MT, Tresgallo RR. Raj A, et al. J Clin Tuberc Other Mycobact Dis. 2024 Jul 26;37:100471. doi: 10.1016/j.jctube.2024.100471. eCollection 2024 Dec. J Clin Tuberc Other Mycobact Dis. 2024. PMID: 39184341 Free PMC article.
The introduction of video-enabled directly observed therapy (video-DOT) for patients with drug-resistant TB disease in Eswatini amid the COVID-19 pandemic - a retrospective cohort study.
Kerschberger B, Daka M, Shongwe B, Dlamini T, Ngwenya S, Danbakli C, Mamba B, Nxumalo B, Sibanda J, Dube S, Dlamini LM, Mabhena E, Mukooza E, Crumley I, Ciglenecki I, Vambe D. Kerschberger B, et al. BMC Health Serv Res. 2024 Jun 3;24(1):699. doi: 10.1186/s12913-024-11151-4. BMC Health Serv Res. 2024. PMID: 38831356 Free PMC article.

See all "Cited by" articles

References

1. TB CARE I. International Standards for Tuberculosis Care. 3. The Hague: TB CARE I; 2014.
1. Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843. - PubMed
1. Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42:156–168. - PMC - PubMed
1. Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013;42:169–179. - PMC - PubMed
1. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943–948. - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

[1] TB CARE I. International Standards for Tuberculosis Care. 3. The Hague: TB CARE I; 2014.

[2] TB CARE I. International Standards for Tuberculosis Care. 3. The Hague: TB CARE I; 2014.

[3] Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843. - PubMed

[4] Gandhi NR, Nunn P, Dheda K, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet. 2010;375:1830–1843. - PubMed

[5] Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42:156–168. - PMC - PubMed

[6] Falzon D, Gandhi N, Migliori GB, et al. Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes. Eur Respir J. 2013;42:156–168. - PMC - PubMed

[7] Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013;42:169–179. - PMC - PubMed

[8] Migliori GB, Sotgiu G, Gandhi NR, et al. Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis. Eur Respir J. 2013;42:169–179. - PMC - PubMed

[9] Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943–948. - PubMed

[10] Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943–948. - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

Affiliations

Video directly observed therapy for treatment of tuberculosis is patient-oriented and cost-effective

Authors

Affiliations

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Conflict of interest statement

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

Related information

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical